publication . Article . 2021

Should Antipyretics Be Used to Relieve Acute Adverse Events Related to COVID-19 Vaccines?

Mahyar Etminan; Mohit Sodhi; Saeed Ganjizadeh-Zavareh;
Open Access
  • Published: 01 Feb 2021 Journal: Chest (issn: 0012-3692, Copyright policy)
  • Publisher: Elsevier BV
Persistent Identifiers
free text keywords: Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, General Interest Commentary and Announcement, Antipyretics, Ibuprofen, Acetaminophen, COVID-19 Vaccines, Adverse Events, Immunogenicity, 2019-20 coronavirus outbreak, Acetaminophen, medicine.drug, medicine, Coronavirus disease 2019 (COVID-19), Immunology, Adverse effect, Immunogenicity, business.industry, business, Ibuprofen, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Antipyretic
Any information missing or wrong?Report an Issue